Zetidoline

This classification denotes an antipsychotic agent with the molecular formula C16H22ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3B5J9TG94X, chemically known as 2-imidazolidinone, 1-(3-chlorophenyl)-3-(2-(3,3-dimethyl-1-azetidinyl)ethyl)- but generally known as zetidoline, which bears US NIH Compound Identifier 72155. European Medicines Agency schedules Zetidoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00149MIG. The term ZETIDOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). ZETIDOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zetidoline under HS 29332990 and SITC 51573. As of Q4 2014, ZETIDOLINE remains the US FDA Preferred Term for this commodity. Zetidoline bears US NLM identifiers UMLS ID C0078761 and NCI Concept Code C66690. SMILES: CLC1CC(N2CCN(CCN3CC(C3)(C)C)C2=O)CCC1.